0001179110-16-020725.txt : 20160302
0001179110-16-020725.hdr.sgml : 20160302
20160302183233
ACCESSION NUMBER: 0001179110-16-020725
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160229
FILED AS OF DATE: 20160302
DATE AS OF CHANGE: 20160302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDICINES CO /DE
CENTRAL INDEX KEY: 0001113481
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043324394
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-290-6000
MAIL ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: MEDICINES CO/ MA
DATE OF NAME CHANGE: 20000504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MEANWELL CLIVE
CENTRAL INDEX KEY: 0001204787
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31191
FILM NUMBER: 161478935
MAIL ADDRESS:
STREET 1: THE MEDICINES CO
STREET 2: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
edgar.xml
FORM 4 -
X0306
4
2016-02-29
0
0001113481
MEDICINES CO /DE
MDCO
0001204787
MEANWELL CLIVE
8 SYLVAN WAY
PARSIPPANY
NJ
07054
1
1
0
0
CEO
Common Stock
2016-02-29
4
A
0
305
27.34
A
314990
D
Common Stock
2016-03-01
4
A
0
45400
0
A
360390
D
Common Stock
2016-03-02
4
F
0
21600
33.85
D
338790
D
Stock Option (right-to-buy)
33.04
2016-03-01
4
A
0
297776
0
A
2026-03-01
Common Stock
297776
297776
D
Shares of common stock acquired pursuant to The Medicines Company Employee Stock Purchase Plan ('ESPP') for the ESPP purchase period beginning September 1, 2015 and ending February 29, 2016. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on February 29, 2016.
Shares of restricted stock vest in 25% increments on each anniversary of the date of grant, until fully vested.
Shares of common stock were withheld for payment of taxes in connection with the vesting of 41,135 shares of restricted stock from previously reported grants.
The option vests in forty-eight equal installments beginning April 1, 2016.
/s/ Stephen M. Rodin, Attorney-in-Fact for Clive A. Meanwell
2016-03-02